Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis

scientific article published on 01 February 1995

Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1600-0420.1995.TB00008.X
P953full work available at URLhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0420.1995.tb00008.x
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-0420.1995.tb00008.x
P698PubMed publication ID7627755

P2093author name stringN. Ehlers
K. Baggesen
J. A. Lomholt
P2860cites workPharmacokinetics of oral acyclovir (Zovirax) in the eye.Q33643138
Evidence for herpes simplex viral latency in the human corneaQ33648607
Biology and Molecular Aspects of Herpes Simplex and Varicell-zoster Virus InfectionsQ35228586
Herpes simplex virus: Molecular biology and the possibility of corneal latencyQ36441661
Herpes simplex keratitis: role of viral infection versus immune responseQ37729970
The changing management and improved prognosis for corneal grafting in herpes simplex keratitisQ38759780
Penetrating keratoplasty in herpes simplex keratitis. Recurrence in graftsQ39620470
The effect of prospective HLA-A and -B matching in 288 penetrating keratoplasties for herpes simplex keratitisQ40188643
Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitisQ43656149
Clinical aspects of herpetic eye diseasesQ46094025
Fresh and cultured corneal grafts compared by post-operative thickness and endothelial cell density.Q50938320
Prognosis and management of corneal transplantation for herpetic keratitisQ67231828
Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survivalQ68190930
Antiviral medication and corneal wound healingQ68837057
Corneal transplantation using long-term cultured donor materialQ68870610
[Oral acyclovir therapy of virologically proven intraocular herpes simplex virus infections]Q70176672
Penetrating keratoplasty for herpes simplex keratitisQ70186623
Corneal Transplantation for Herpes Simplex KeratitisQ70254497
Longterm prognosis for corneal grafting in herpes simplex keratitisQ70266155
Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyQ83980808
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)29-32
P577publication date1995-02-01
P1433published inActa OphthalmologicaQ15716498
P1476titleRecurrence and rejection rates following corneal transplantation for herpes simplex keratitis
P478volume73

Reverse relations

cites work (P2860)
Q41304358Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty
Q35208768Antiviral treatment following penetrating keratoplasty for herpetic keratitis
Q44605033Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial
Q42242985Gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex vivo.
Q37106320HSV keratitis: histopathologic predictors of corneal allograft complications
Q34179862Herpes simplex virus keratitis: histopathologic inflammation and corneal allograft rejection
Q34113969Herpes simplex virus keratitis: histopathologic neovascularization and corneal allograft failure
Q30728400Long-term results of penetrating keratoplasty. A 10-year-plus retrospective study
Q34757252Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells
Q35590400Pathogenesis and management of herpes simplex virus keratitis
Q81329698Persistent epithelial defects and ulcers in repeated corneal transplantation: incidence, causative agents, predisposing factors and treatment outcomes
Q35589785The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin
Q50963311Therapeutic effect of deep anterior lamellar keratoplasty for active or quiescent herpetic stromal keratitis.

Search more.